What is Albert David Ltd (ALBERTDAVD) share price return in the past 10 years?

Albert David Ltd share price has appreciated 9% annually (CAGR) over the past ten years.

What is the share price of Albert David Ltd (ALBERTDAVD)?

Company share prices are keep on changing according to the market conditions. The current trading price of Albert David Ltd (ALBERTDAVD) on 04-Jun-2026 16:59:59 at 16:59 is 721.95.

What is the P/E ratio of Albert David?

The latest standalone P/E ratio of Albert David as of 04-Jun-2026 is 0.00.

What is the P/B ratio of Albert David Ltd (ALBERTDAVD)?

The latest standalone P/B ratio of Albert David Ltd (ALBERTDAVD) as of 04-Jun-2026 is 1.05.

What is the 52-week high and low of Albert David Ltd (ALBERTDAVD)?

The 52-week high of Albert David Ltd (ALBERTDAVD) is Rs. 959.35 and the 52-week low is Rs. 581.30.

Albert David Ltd (ALBERTDAVD) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Albert David Ltd (ALBERTDAVD)
Brand: Albert David

Albert David Ltd (ALBERTDAVD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524075 NSE: ALBERTDAVD Pharmaceuticals & Drugs | Small Cap | Albert David Share Price

Albert David Ltd (ALBERTDAVD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524075 NSE: ALBERTDAVD Pharmaceuticals & Drugs | Small Cap | Albert David Share Price

Key Metrics

Valuation Multiples

Market Cap

₹412 Cr.

Current Price

₹722

52-Week Low / High

₹581 / 959

TTM EPS

₹-2.6

TTM Sales

₹334 Cr.

Book Value per Share

₹686

P/E Ratio

0.00

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

1.05

Lower than its 5-year historical median

Price to Sales (P/S)

1.24

In line with its 5-year historical median

EV/EBITDA

31.56

Higher than its 5-year historical median

Dividend Yield

0.62%

Profitability Efficiency

Return on Equity (ROE)

4.44%

Underperforms industry median

Return on Capital Employed (ROCE)

6.54%

Underperforms industry median

Return on Assets (ROA)

2.80%

Operating Profit Margin

1.2%

Net Profit Margin

4.97%

Gross Profit Margin

8.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-4.6%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-93.28%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-77.19%

Asset Quality

Promoter Holding

62.24%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹386 Cr.

Equity

₹5.7 Cr.

Face Value

₹10

All Time Low / High

₹3.15 / 1752.95

Albert David stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Albert David Ltd a good quality company?

Albert David Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Albert David Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Albert David Ltd vs industry peers?

Albert David Ltd revenue CAGR is 1.51%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Albert David Ltd?

Promoters hold 62.24% of the Albert David Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Albert David Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 8.8% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	46.5%	14.3%	7.9%	20.6%	13.7%	12%	18.1%	17.1%	27.9%	6.5%	-
Value Creation Index ⓘ	2.3	0.0	-0.4	0.5	0.0	-0.1	0.3	0.2	1.0	-0.5	-
Growth Parameters ⓘ
Sales ⓘ	323	295	290	317	321	247	314	342	362	346	334
Sales YoY Gr.	-	-8.5%	-1.7%	9.3%	1.1%	-22.9%	26.7%	9%	6.1%	-4.6%	-
Adj EPS ⓘ	33.3	23.7	11.4	26	36.4	37	57.1	62.9	130.3	30.8	-2.6
YoY Gr.	-	-28.8%	-52%	128.7%	39.8%	1.6%	54.4%	10.1%	107.2%	-76.3%	-
BVPS (₹) ⓘ	239.8	320.7	325.8	368.7	390.4	428.2	489.7	545.9	671.1	687.7	686
Adj Net Profit ⓘ	19	13.5	6.5	14.9	20.8	21.1	32.6	35.9	74.3	17.6	-1
Cash Flow from Ops. ⓘ	68	19.9	30	31.9	30.3	36.6	40.4	10.5	45.5	-28.4	-
Debt/CF from Ops. ⓘ	0.3	1.5	0.9	0	0.1	0	0.1	0.5	0.1	-0.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	0.8%	1.5%	3.3%	-4.6%
Adj EPS ⓘ	-0.9%	-3.3%	-18.6%	-76.3%
BVPSⓘ	12.4%	12%	12%	2.5%
Share Price	9%	8.9%	8.6%	-9.8%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	16.6	8.5	3.5	7.5	9.6	9	12.4	12.1	21.4	4.5	-0.4
Op. Profit Mgn % ⓘ	9.7	6.6	5.9	9.4	10.6	7.8	13.1	13.2	13	1.2	1.6
Net Profit Mgn % ⓘ	5.9	4.6	2.2	4.7	6.5	8.5	10.4	10.5	20.5	5.1	-0.5
Debt to Equity ⓘ	0.2	0.2	0.2	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	161	194	212	193	190	227	183	201	201	232	201
Cash Conv. Cycle ⓘ	62	62	47	32	28	36	27	32	31	39	138

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	323	295	290	317	321	247	314	342	362	346
Operating Expenses ⓘ +	291	277	275	288	290	228	273	297	315	343
Manufacturing Costs	66	54	56	55	54	33	50	65	62	61
Material Costs	60	56	60	75	74	70	87	87	91	82
Employee Cost	82	83	86	90	90	83	85	81	88	109
Other Costs ⓘ	84	84	73	68	72	43	50	64	74	90
Operating Profit ⓘ	31	18	16	29	31	19	41	44	47	3
Operating Profit Margin (%)	9.7%	6.1%	5.4%	9.2%	9.5%	7.8%	13.1%	13.0%	13.0%	0.9%
Other Income ⓘ +	2	16	10	21	7	17	16	15	58	30
Exceptional Items ⓘ	41	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	1	1	1	1	1	1	1	0	1
Depreciation ⓘ	9	8	8	7	8	8	9	9	7	7
Profit Before Tax ⓘ	63	26	16	43	29	27	47	51	97	25
Tax ⓘ	15	10	6	16	10	5	12	15	22	8
Profit After Tax	48	16	10	27	19	22	35	36	75	17
PAT Margin (%)	14.9%	5.4%	3.4%	8.4%	6.0%	9.0%	11.3%	10.6%	20.8%	5.0%
Adjusted EPS (₹)	84.1	28.0	17.2	46.7	33.6	38.8	61.8	63.4	132.2	30.1
Dividend Payout Ratio (%)	6.50%	19.70%	31.90%	12.90%	20.80%	15.50%	14.60%	14.20%	8.70%	16.60%

Valuation of Albert David - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	137	183	186	210	223	244	279	312	383	392
Share Capital ⓘ	6	6	6	6	6	6	6	6	6	6
Reserves ⓘ	131	177	180	205	217	239	274	306	377	387
Debt +	20	30	28	0	1	1	4	4	2	10
Long Term Debt	0	0	0	0	1	0	0	0	0	0
Short Term Debt	20	30	28	0	0	0	4	4	2	10
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	27	27	32	30	38	25	30	32	34	38
Others Liabilities ⓘ	81	110	116	135	136	135	161	165	185	184
Total Liabilities ⓘ	265	351	361	376	398	405	475	512	604	625
Fixed Assets
Net Fixed Assets ⓘ +	44	87	83	77	91	84	88	80	83	99
Gross Block	172	221	192	192	212	212	223	222	230	251
Accumulated Depreciation	127	134	109	115	121	128	135	142	147	152
CWIP ⓘ	5	9	5	5	2	1	1	3	7	2
Investments ⓘ	48	59	68	113	122	138	183	193	273	260
Inventories	49	51	43	44	43	36	39	51	44	64
Trade Receivables	35	33	27	22	30	19	25	30	29	27
Cash Equivalents	23	15	26	7	7	35	19	25	31	2
Others Assets ⓘ	60	98	109	108	104	92	121	131	137	171
Total Assets ⓘ	265	351	361	376	398	405	475	512	604	625

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	68	20	30	32	30	37	40	11	46	-28
PBT ⓘ	22	26	16	43	29	27	47	51	97	25
Adjustment ⓘ	63	2	3	-13	7	-7	-6	1	-44	-16
Changes in Working Capital ⓘ	10	3	19	8	9	19	11	-26	9	-29
Tax Paid ⓘ	-27	-11	-7	-6	-15	-2	-13	-16	-16	-9
Cash Flow From Investing Activity ⓘ +	-38	-37	-11	-19	-20	-39	-40	-5	-33	23
Capex	-6	-20	1	14	-15	-1	-9	-5	-11	-15
Net Investments	-32	-9	-6	-39	-9	-40	-42	1	-33	34
Others ⓘ	-0	-8	-6	7	4	3	11	-1	11	4
Cash Flow From Financing Activity ⓘ +	-18	7	-5	-17	-10	-2	-2	-6	-8	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-8	0	0	0	-1	-1	0	0	0	0
Interest Paid ⓘ	-2	-1	-0	-0	-1	-0	-0	-0	-0	-0
Dividend Paid ⓘ	-6	-1	-4	-4	-9	-0	-3	-5	-5	-7
Others ⓘ	-2	8	-0	-13	-0	-0	2	-1	-3	7
Net Cash Flow ⓘ	12	-10	14	-4	-0	-4	-1	-1	4	-5

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	41.8	9.98	5.33	13.44	8.85	9.48	13.46	12.24	21.72	4.44
ROCE (%)	46.48	14.29	7.94	20.6	13.74	11.99	18.1	17.1	27.87	6.54
Asset Turnover Ratio	1.35	1	0.87	0.9	0.87	0.65	0.75	0.73	0.69	0.6
PAT to CFO Conversion(x)	1.42	1.25	3	1.19	1.58	1.68	1.14	0.31	0.61	-1.65
Working Capital Days
Receivable Days	41.90	40.80	35.50	26.90	28.10	34.80	24.60	28	28.40	27.90
Inventory Days	55	59.10	55.20	47.80	46.90	55	41.40	45.50	44.90	52.80
Payable Days	157.30	166.50	180.80	149.40	166.80	164.80	115.20	130.60	132.70	158.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Albert David Ltd FAQs

The current trading price of Albert David on 04-Jun-2026 16:59 is ₹722.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Albert David stood at ₹412.0 Cr

The latest P/E ratio of Albert David as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Albert David as of 03-Jun-2026 is 1.05.

The 52-week high of Albert David is ₹959.4 and the 52-week low is ₹581.3.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Albert David is ₹334 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Albert David Ltd is a good quality company.

The key valuation ratios of Albert David Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Albert David Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Albert David Ltd

Albert David was incorporated in the year 1938. The company is a part of Kothari group.

Albert David, which has decades of illustrious presence in the health care industry, manufactures pharmaceutical formulations and bulk drugs, infusion solutions and oral solids, disposable syringes and needles and herbal formulations. The company exports these products to Vietnam, Russia, Belarus, Egypt, Bangladesh, Kenya, Tanzania, Uganda, Sudan, Ethiopia, Nigeria, Zaire, Haiti, Brazil, Canada, USA, UK, Netherlands and Germany as the company is a WHO-approved supplier.

It also has DMF for the bulk drugs, Tolbutamide and Chlorpropamide with the US Food and Drugs Administration (USFDA). The manufacturing facility for these products has been inspected and validated by the US drug regulator.

The manufacturing plants of the company are located at Ghaziabad near New Delhi, Kolkata and Mandideep near Bhopal.

The company`s amino acid range under the brand name of Alamin contains pure crystalline amino acid of high international standards manufactured under a unique technology, which conforms to WHO and FAO recommendations. In the herbal segment, the company sells its products under brand names like Adliv, which is a hepato protective and Siotone capsule, which is the only adaptogen indicated for stress.

ADL has tie-ups with Ajinomoto Co and Roussel Morishita Co of Japan for manufacturing and marketing a wide range of crystalline amino acid infusion solutions, oral solids and liquids in India.

Products offered by the Company:

The company is operating in major therapeutic segments that include:

Analgesics/AntiInflammatory
Anti-Bacterials
Anti-Ulcerants
Dermatologicals
Anxiolytics
Large Volume Parenteral
Disposable Syringes & Needles
Herbal Drugs
Nutrition
Neurotropics
Placental Extracts
Anthelmintic
Haemostati
Cough Preparations
Laxatives
Skeletal Relaxants
Anti-Arthiritic / Chondroprotective Agents.

Future Plans:

The company will explore the possibilities for export of its IV fluids, small volume parenterals and disposable syringes in addition to its existing range.
It will concentrate on product line extension for its flagship brand Placentrex by bringing in newer formulations and looking for a new therapeutic area of usage.
Future expansion in the herbal product range will be focused in the area of women`s healthcare.
ADL is planning to enter newer therapeutic areas like dermatological and ophthalmological segments.
Furthermore, it will also strengthen its presence in the gastrointestinal segments and in the areas of pain management.
The company is also planning to launch newer products in the areas of nutritional, gynaecological and herbal medicine.

Albert David Ltd (ALBERTDAVD)

Albert David Ltd (ALBERTDAVD)

Albert David stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Albert David - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Albert David Ltd FAQs

About Albert David Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Albert David Ltd (ALBERTDAVD)

Albert David Ltd (ALBERTDAVD)

Albert David stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Albert David - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Albert David Ltd FAQs

What is the share price of Albert David?

What is the market cap of Albert David?

What is the P/E ratio of Albert David?

What is the P/B ratio of Albert David?

What is the 52-week high and low of Albert David?

What is the TTM revenue of Albert David?

Is Albert David Ltd a good quality company?

Is Albert David Ltd undervalued or overvalued?

Is Albert David Ltd a good buy now?

About Albert David Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.